# Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers

> **NCT03362398** · NA · COMPLETED · sponsor: **British University In Egypt** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Omarigliptin 25 mg
- **DRUG:** Trelagliptin 100 mg

## Key facts

- **NCT ID:** NCT03362398
- **Lead sponsor:** British University In Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-20
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-28
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03362398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03362398, "Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03362398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*